Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongliang Shen

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 16, 2020
ZSCAN16 promotes proliferation, migration and invasion of bladder cancer via regulating NF-kB, AKT, mTOR, P38 and other genesXuanhao Li, Donghao Shang, Hongliang Shen, et al.
Journal of Analytical Toxicology|May 17, 2019
Comparison of the Detection Windows of Heroin Metabolites in Human Urine Using Online SPE and LC-MS/MS: Importance of Morphine-3-GlucuronideLuying Wang, Chunfang Ni, Hongliang Shen, et al.
Genetic Testing and Molecular Biomarkers|November 28, 2017
Curcumin Suppresses In Vitro Proliferation and Invasion of Human Prostate Cancer Stem Cells by Modulating DLK1-DIO3 Imprinted Gene Cluster MicroRNAsHu Zhang, Jiajia Zheng, Hongliang Shen, et al.
Journal of Materials Chemistry. B|July 15, 2026
A multi-target nano-therapy against cerebral ischemia/reperfusion injury <i>via</i> combinatorial inhibition of neuroinflammation and pyroptosisWenchao Fu, Ayang Zhao, Bo Chen, et al.
ANZ Journal of Surgery|October 26, 2010
Evaluating the safety of the Harmonic Scalpel around the recurrent laryngeal nerveHang Jiang, Hongliang Shen, Daozhen Jiang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 22, 2024
Enhancing surgical outcomes: accurate identification and removal of prostate cancer with B7-H3-targeted NIR-II molecular imagingYaqi Tian, Hongliang Shen, Lingbing Li, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 29, 2020
LncRNA NR2F2-AS1 Upregulates Rac1 to Increase Cancer Stemness in Clear Cell Renal Cell CarcinomaLin Chen, Dongxing Zhang, Tao Ding, et al.
Cardiovascular and Interventional Radiology|May 28, 2026
Comparison of Single Fiber Transperineal Laser Ablation and Radiofrequency Ablation in the Treatment of Benign Prostatic HyperplasiaXiao Han, Peipei Yang, Xinyu Zhao, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 28, 2015
CXCL5 is a potential diagnostic and prognostic marker for bladder cancer patientsXi Zhu, Yan Qiao, Weihua Liu, et al.
Journal of Cellular and Molecular Medicine|November 10, 2018
Fisetin decreases TET1 activity and CCNY/CDK16 promoter 5hmC levels to inhibit the proliferation and invasion of renal cancer stem cellYibing Si, Junfeng Liu, Hongliang Shen, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 16, 2020
ZSCAN16 promotes proliferation, migration and invasion of bladder cancer via regulating NF-kB, AKT, mTOR, P38 and other genesXuanhao Li, Donghao Shang, Hongliang Shen, et al.
Journal of Analytical Toxicology|May 17, 2019
Comparison of the Detection Windows of Heroin Metabolites in Human Urine Using Online SPE and LC-MS/MS: Importance of Morphine-3-GlucuronideLuying Wang, Chunfang Ni, Hongliang Shen, et al.
Genetic Testing and Molecular Biomarkers|November 28, 2017
Curcumin Suppresses In Vitro Proliferation and Invasion of Human Prostate Cancer Stem Cells by Modulating DLK1-DIO3 Imprinted Gene Cluster MicroRNAsHu Zhang, Jiajia Zheng, Hongliang Shen, et al.
Journal of Materials Chemistry. B|July 15, 2026
A multi-target nano-therapy against cerebral ischemia/reperfusion injury <i>via</i> combinatorial inhibition of neuroinflammation and pyroptosisWenchao Fu, Ayang Zhao, Bo Chen, et al.
ANZ Journal of Surgery|October 26, 2010
Evaluating the safety of the Harmonic Scalpel around the recurrent laryngeal nerveHang Jiang, Hongliang Shen, Daozhen Jiang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 22, 2024
Enhancing surgical outcomes: accurate identification and removal of prostate cancer with B7-H3-targeted NIR-II molecular imagingYaqi Tian, Hongliang Shen, Lingbing Li, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 29, 2020
LncRNA NR2F2-AS1 Upregulates Rac1 to Increase Cancer Stemness in Clear Cell Renal Cell CarcinomaLin Chen, Dongxing Zhang, Tao Ding, et al.
Cardiovascular and Interventional Radiology|May 28, 2026
Comparison of Single Fiber Transperineal Laser Ablation and Radiofrequency Ablation in the Treatment of Benign Prostatic HyperplasiaXiao Han, Peipei Yang, Xinyu Zhao, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 28, 2015
CXCL5 is a potential diagnostic and prognostic marker for bladder cancer patientsXi Zhu, Yan Qiao, Weihua Liu, et al.
Journal of Cellular and Molecular Medicine|November 10, 2018
Fisetin decreases TET1 activity and CCNY/CDK16 promoter 5hmC levels to inhibit the proliferation and invasion of renal cancer stem cellYibing Si, Junfeng Liu, Hongliang Shen, et al.
Pageof 3